{"cik":"0001674632","ticker":"BBNX","name":"Beta Bionics, Inc.","sic_code":null,"sic_description":null,"exchange":"Nasdaq","state_of_incorporation":null,"fiscal_year_end":null,"first_filing_date":"2026-05-08","last_filing_date":"2026-05-12","url":"/sec/cik-0001674632","insider_summary":{"total_transactions":0,"unique_insiders":0,"latest_transaction":null},"recent_filings":[{"accession_number":"0000908834-26-000226","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-12","title":"SCHEDULE 13G/A — Farallon Capital Partners, L.P. — 2026-05-12","url_slug":"/sec/cik-0001175707/schedule-13g-a/0000908834-26-000226","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674632/0000908834-26-000226-index.html"},{"accession_number":"0001213900-26-053982","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-08","title":"SCHEDULE 13G/A — Beta Bionics, Inc. — 2026-05-08","url_slug":"/sec/cik-0001674632/schedule-13g-a/0001213900-26-053982","edgar_url":"https://www.sec.gov/Archives/edgar/data/1674632/0001213900-26-053982-index.html"}],"related_endpoints":{"profile":"/sec/BBNX/profile","timeline":"/sec/BBNX/timeline","peers":"/sec/BBNX/peers","insider_pulse":"/sec/BBNX/insider-pulse","insider_summary":"/sec/BBNX/insider-summary","insider_transactions":"/sec/BBNX/insider-transactions","form144":"/sec/BBNX/form144","holdings_as_filer":"/sec/BBNX/holdings","financial_facts":"/sec/BBNX/financial-facts","derivatives":"/sec/BBNX/derivatives","officers":"/sec/BBNX/officers","insider_network":"/sec/BBNX/insider-network","risk_flags":"/sec/BBNX/risk-flags","filings":"/sec/BBNX/filings","cross_topic_dossier":"/api/v1/dossier?ticker=BBNX"}}